Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial | Zendy

Otto Metzger | Zendy; Anita GiobbieHurder | Zendy; Elizabeth Mallon | Zendy; Barry A. Gusterson | Zendy; Giuseppe Viale | Zendy; Eric P. Winer | Zendy; Beat Thürlimann | Zendy; Richard D. Gelber | Zendy; Marco Colleoni | Zendy; Bent Ejlertsen | Zendy; Marc Debled | Zendy; Karen N. Price | Zendy; Meredith M. Regan | Zendy; Alan S. Coates | Zendy; Aron Goldhirsch | Zendy

AI Assistant Blog Pricing

Open Access

Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial

Author(s) -

Otto Metzger,

Anita GiobbieHurder,

Elizabeth Mallon,

Barry A. Gusterson,

Giuseppe Viale,

Eric P. Winer,

Beat Thürlimann,

Richard D. Gelber,

Marco Colleoni,

Bent Ejlertsen,

Marc Debled,

Karen N. Price,

Meredith M. Regan,

Alan S. Coates,

Aron Goldhirsch

Publication year - 2015

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2015.60.8133

Subject(s) - medicine , letrozole , hazard ratio , tamoxifen , ductal carcinoma , lobular carcinoma , oncology , proportional hazards model , breast cancer , gastroenterology , urology , confidence interval , cancer

To evaluate the relative effectiveness of letrozole compared with tamoxifen for patients with invasive ductal or lobular carcinoma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog